Results 281 to 290 of about 7,597,050 (334)

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

open access: yesMolecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala   +15 more
wiley   +1 more source

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

open access: yesMolecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung   +17 more
wiley   +1 more source

SARS-CoV-2 altered mitochondrial DNA methylation in Indian COVID-19 patients. [PDF]

open access: yesSci Rep
Kumari D   +8 more
europepmc   +1 more source

Reference Gene Stability in <i>Agrostemma githago</i> Using Quantitative Real-Time PCR. [PDF]

open access: yesInt J Mol Sci
Bielecka M   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy